Literature DB >> 17490685

The prevention of the dementia epidemic.

Amos D Korczyn1, Veronika Vakhapova.   

Abstract

Alzheimer's disease (AD) is considered to be the most common dementing disorder. The understanding of this disorder has greatly advanced over the past few years, and new therapeutic options have been developed. Another disorder, vascular dementia (VaD), is a syndrome with multiple etiologies operating through a variety of different mechanisms. The combination of AD and VaD is extremely common, making mixed dementia the most common type of dementia. Risk factors for VaD, which are the common vascular risk factors, are presently known to apply also to AD. Cholinergic deficits occur in both conditions. The identification of several genetic factors that can contribute to vascular damage, as well as possible auto-immune damage to vascular components, are important. It is remarkable that amyloid precursor protein (APP) mutations can cause the typical pathological changes of AD as well as amyloid deposition around blood vessels. These may lead to deficient blood perfusion to the brain, changes of the blood-brain barrier, as well as cerebral hemorrhages. Interestingly, attention to risk factors, such as hypertension, coronary artery disease, hyperlipidemia and smoking could reduce or delay the incidence of dementia, both vascular and AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490685     DOI: 10.1016/j.jns.2007.01.081

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

Review 1.  Neuroprotective effect of natural products against Alzheimer's disease.

Authors:  Musthafa M Essa; Reshmi K Vijayan; Gloria Castellano-Gonzalez; Mustaq A Memon; Nady Braidy; Gilles J Guillemin
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

2.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

Review 3.  Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

Review 4.  Vascular risk factors, alcohol intake, and cognitive decline.

Authors:  F Panza; C Capurso; A D'Introno; A M Colacicco; V Frisardi; A Santamato; M Ranieri; P Fiore; G Vendemiale; D Seripa; A Pilotto; A Capurso; V Solfrizzi
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

5.  Leukocyte telomere length is associated with cognitive performance in healthy women.

Authors:  A M Valdes; I J Deary; J Gardner; M Kimura; X Lu; T D Spector; A Aviv; L F Cherkas
Journal:  Neurobiol Aging       Date:  2008-08-20       Impact factor: 4.673

Review 6.  Vascular dementia.

Authors:  Amos D Korczyn; Veronika Vakhapova; Lea T Grinberg
Journal:  J Neurol Sci       Date:  2012-05-08       Impact factor: 3.181

Review 7.  Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy.

Authors:  Ashwani Arya; Rubal Chahal; Rekha Rao; Md Habibur Rahman; Deepak Kaushik; Muhammad Furqan Akhtar; Ammara Saleem; Shaden M A Khalifa; Hesham R El-Seedi; Mohamed Kamel; Ghadeer M Albadrani; Mohamed M Abdel-Daim; Vineet Mittal
Journal:  Biomolecules       Date:  2021-02-25

8.  Pilot data on telmisartan short-term effects on glucose metabolism in the olfactory tract in Alzheimer's disease.

Authors:  Etsuko Imabayashi; Hiroshi Matsuda; Kimiko Yoshimaru; Ichiei Kuji; Akira Seto; Yasumasa Shimano; Kimiteru Ito; Daisuke Kikuta; Tomokazu Shimazu; Nobuo Araki
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

9.  Risks for central nervous system diseases among mobile phone subscribers: a Danish retrospective cohort study.

Authors:  Joachim Schüz; Gunhild Waldemar; Jørgen H Olsen; Christoffer Johansen
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

10.  Is dementia preventable?

Authors:  Amos D Korczyn
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.